[HTML][HTML] Prospective multicenter validation of androgen receptor splice variant 7 and hormone therapy resistance in high-risk castration-resistant prostate cancer: the …
…, B Thornburg, WR Berry, RS Wilder… - Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
PURPOSE Androgen receptor splice variant 7 (AR-V7) results in a truncated receptor,
which leads to ligand-independent constitutive activation that is not inhibited by anti-androgen …
which leads to ligand-independent constitutive activation that is not inhibited by anti-androgen …
[HTML][HTML] Inhaled fluticasone furoate for outpatient treatment of Covid-19
…, G Hanna, A Remaly, F Thicklin, R Wilder… - … England Journal of …, 2023 - Mass Medical Soc
Background The effectiveness of inhaled glucocorticoids in shortening the time to symptom
resolution or preventing hospitalization or death among outpatients with mild-to-moderate …
resolution or preventing hospitalization or death among outpatients with mild-to-moderate …
Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial
…, SJ Adam, A DeLong, G Hanna, A Remaly, R Wilder… - Jama, 2022 - jamanetwork.com
Importance The effectiveness of ivermectin to shorten symptom duration or prevent hospitalization
among outpatients in the US with mild to moderate symptomatic COVID-19 is unknown…
among outpatients in the US with mild to moderate symptomatic COVID-19 is unknown…
Effect of higher-dose ivermectin for 6 days vs placebo on time to sustained recovery in outpatients with COVID-19: a randomized clinical trial
…, S Wilson, A DeLong, A Remaly, R Wilder… - JAMA, 2023 - jamanetwork.com
Importance It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg,
shortens symptom duration or prevents hospitalization among outpatients with mild to …
shortens symptom duration or prevents hospitalization among outpatients with mild to …
Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial
…, S Wilson, A DeLong, A Remaly, R Wilder… - JAMA, 2023 - jamanetwork.com
Importance The effectiveness of fluvoxamine to shorten symptom duration or prevent
hospitalization among outpatients with mild to moderate symptomatic COVID-19 is unclear. …
hospitalization among outpatients with mild to moderate symptomatic COVID-19 is unclear. …
Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling
The Rheb1 and Rheb2 small GTPases and their effector mTOR are aberrantly activated in
human cancer and are attractive targets for anti-cancer drug discovery. Rheb is targeted to …
human cancer and are attractive targets for anti-cancer drug discovery. Rheb is targeted to …
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer
…, M Anand, C Winters, C Riggan, J Kephart, R Wilder… - Cancer, 2021 - Wiley Online Library
Background Retrospective analyses of randomized trials suggest that Black men with metastatic
castration‐resistant prostate cancer (mCRPC) have longer survival than White men. The …
castration‐resistant prostate cancer (mCRPC) have longer survival than White men. The …
Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19: The ACTIV-6 randomized clinical trial
Importance The effect of higher-dose fluvoxamine in reducing symptom duration among
outpatients with mild to moderate COVID-19 remains uncertain. Objective To assess the …
outpatients with mild to moderate COVID-19 remains uncertain. Objective To assess the …
[HTML][HTML] Requirement for C-terminal sequences in regulation of Ect2 guanine nucleotide exchange specificity and transformation
PA Solski, RS Wilder, KL Rossman, J Sondek… - Journal of Biological …, 2004 - ASBMB
Ect2 was identified originally as a transforming protein and a member of the Dbl family of Rho
guanine nucleotide exchange factors (GEFs). Like all Dbl family proteins, Ect2 contains a …
guanine nucleotide exchange factors (GEFs). Like all Dbl family proteins, Ect2 contains a …
Phase II trial of enzalutamide and androgen deprivation therapy with salvage radiation in men with high-risk prostate-specific antigen recurrent prostate cancer: the …
…, C Winters, C Riggan, J Rasmussen, R Wilder… - European urology …, 2021 - Elsevier
Background Salvage external beam radiotherapy (RT) with androgen deprivation therapy (ADT)
improves survival over RT in men with prostate cancer (PC) and rising prostate-specific …
improves survival over RT in men with prostate cancer (PC) and rising prostate-specific …